跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“LYMERix”
全部
18
临床试验
3
药物
1
机构
1
资讯
13
5年前
Real-World Study Confirms Lyme Vaccine Effectiveness Before Market Withdrawal
18天前
Pfizer-Valneva Lyme Vaccine Nears FDA Filing as Court Injunction Freezes the Panel That Would Guide Its Rollout
4年前
Pfizer and Valneva's Lyme Disease Vaccine Candidate Enters Phase 3 Trial
去年
Valneva-Pfizer Lyme Disease Vaccine Shows Promise with Strong Booster Response in Phase 2 Trial
去年
Dimerix Partners with NEPTUNE to Accelerate FSGS Trial Recruitment
去年
Dimerix Advances Kidney Disease Trial with Key Endpoint Validation
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
2年前
Dimerix Partners with UK National Registry to Accelerate ACTION3 Trial for FSGS
去年
Biotech Dimerix lands $940m licensing deal for kidney drug sales - AFR
去年
Dimerix Licenses Phase 3 FSGS Drug DMX-200 to FUSO Pharma for ¥10.5 Billion
第 1 页,共 2 页
上一页
下一页